$372.63
0.10% today
NYSE, Apr 01, 06:15 pm CET
ISIN
US8636671013
Symbol
SYK

Stryker Stock price

$372.25
-13.94 3.61% 1M
+10.99 3.04% 6M
+12.20 3.39% YTD
+17.58 4.96% 1Y
+104.90 39.24% 3Y
+205.76 123.59% 5Y
+280.00 303.52% 10Y
NYSE, Closing price Mon, Mar 31 2025
+7.75 2.13%
ISIN
US8636671013
Symbol
SYK
Sector

Key metrics

Market capitalization $142.08b
Enterprise Value $151.71b
P/E (TTM) P/E ratio 47.95
EV/FCF (TTM) EV/FCF 43.51
EV/Sales (TTM) EV/Sales 6.71
P/S ratio (TTM) P/S ratio 6.29
P/B ratio (TTM) P/B ratio 6.88
Dividend yield 0.87%
Last dividend (FY24) $3.24
Revenue growth (TTM) Revenue growth 10.23%
Revenue (TTM) Revenue $22.60b
EBIT (operating result TTM) EBIT $5.03b
Free Cash Flow (TTM) Free Cash Flow $3.49b
Cash position $4.49b
EPS (TTM) EPS $7.76
P/E forward 31.94
P/S forward 5.79
EV/Sales forward 6.18
Short interest 1.46%
Show more

Is Stryker a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Stryker Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a Stryker forecast:

23x Buy
70%
9x Hold
27%
1x Sell
3%

Analyst Opinions

33 Analysts have issued a Stryker forecast:

Buy
70%
Hold
27%
Sell
3%

Financial data from Stryker

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
22,595 22,595
10% 10%
100%
- Direct Costs 8,695 8,695
8% 8%
38%
13,900 13,900
11% 11%
62%
- Selling and Administrative Expenses 6,409 6,409
10% 10%
28%
- Research and Development Expense 1,414 1,414
9% 9%
6%
6,077 6,077
13% 13%
27%
- Depreciation and Amortization 1,050 1,050
2% 2%
5%
EBIT (Operating Income) EBIT 5,027 5,027
16% 16%
22%
Net Profit 2,993 2,993
5% 5%
13%

In millions USD.

Don't miss a Thing! We will send you all news about Stryker directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Stryker Stock News

Neutral
GlobeNewsWire
6 days ago
Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company's board at the 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025.
Neutral
GlobeNewsWire
7 days ago
Portage, Michigan, March 25, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2025 Annual Meeting of Shareholders is scheduled as follows:
Neutral
PRNewsWire
21 days ago
Latest technology offers more applications and innovation across more specialties MAHWAH, N.J. , March 11, 2025 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego.
More Stryker News

Company Profile

Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Head office United States
CEO Kevin Lobo
Employees 53,000
Founded 1941
Website www.stryker.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today